Abstract
Semiconductor quantum dots represent a novel class of fluorophores with unique physical and chemical properties which could enable a remarkable broadening of the current applications of fluorescent imaging and optical diagnostics. Complexes of quantum dots and antibodies are promising visualising agents for fluorescent detection of selective biomarkers overexpressed in tumor tissues. Here we describe the construction of self-assembling fluorescent complexes of quantum dots and anti-HER1 or anti-HER2/neu scFv antibodies and their interactions with cultured tumor cells. A binding strategy based on a very specific non-covalent interaction between two proteins, barnase and barstar, was used to connect quantum dots and the targeting antibodies. Such a strategy allows combining the targeting and visualization functions simply by varying the corresponding modules of the fluorescent complex.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies / chemistry
-
Bacterial Proteins / chemistry
-
Biomarkers, Tumor / metabolism
-
CHO Cells
-
Cell Line, Tumor
-
Cell Membrane / metabolism
-
Cricetinae
-
Electrophoresis
-
Escherichia coli / metabolism
-
Flow Cytometry / methods
-
Fluorescent Dyes / pharmacology
-
Humans
-
Neoplasms / immunology*
-
Neoplasms / metabolism
-
Quantum Dots*
-
Recombinant Proteins / metabolism
-
Ribonucleases / chemistry
-
Single-Chain Antibodies / chemistry*
-
Tumor Cells, Cultured
Substances
-
Antibodies
-
Bacterial Proteins
-
Biomarkers, Tumor
-
Fluorescent Dyes
-
Recombinant Proteins
-
Single-Chain Antibodies
-
barstar protein, Bacillus amyloliquefaciens
-
Ribonucleases
-
Bacillus amyloliquefaciens ribonuclease
Grants and funding
This research was supported by the Russian Foundation for Basic Research (project nos. 12-04-00757-a, 11-04-12091-ofi-m-2011, and 10-04-01506), Presidium of Russian Academy of Sciences (Molecular & Cellular Biology and Nanotechnologies & Nanomaterials) and the Ministry of Education and Science of the Russian Federation (project nos. 16.740.11.0497, 14.740.11.0253, 16.512.11.2053 and 11.G 34. 31.0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.